Aro Biotherapeutics Co.

Big pharma participation in venture capital financing has become increasingly important as other investors hesitate to fund the biopharmaceutical sector based on macroeconomic unease. With even health

As the major introductory fundraise for start-ups, Series A financings represent the first-time companies raise substantial equity from venture investors. Prior to the Series A, new firms may raise fu

The week before the annual J.P. Morgan Healthcare Conference always includes a bevy of new financings and the week before this year’s 11-14 January meeting kept up with the tradition with $1.67bn in v